Equity - Warrants (Details) - USD ($)					12 Months Ended
	Nov. 06, 2023	Jun. 26, 2023	Apr. 20, 2020	Jul. 17, 2019	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Number of Underlying Shares
Outstanding, beginning balance (in shares)					392,155	512,155
Outstanding, end balance (in shares)					11,308,314	392,155	512,155
Weighted Average Exercise Price Per Share
Outstanding, beginning balance (in dollars per share)					$ 8.58	$ 8.62
Outstanding, end balance (in dollars per share)					$ 1.09	$ 8.58	$ 8.62
June 2023 pre-funded warrants
Number of Underlying Shares
Granted during the period (in shares)					637,587
Exercised during period (in shares)					(637,587)
Weighted Average Exercise Price Per Share
Granted (in dollars per share)					$ 0.0001
Exercised during period (in dollar per share)					0.0001
Outstanding, end balance (in dollars per share)					$ 0.0001
June 2023 warrants
Number of Underlying Shares
Granted during the period (in shares)					1,427,587
Outstanding, end balance (in shares)					1,427,587
Weighted Average Exercise Price Per Share
Granted (in dollars per share)					$ 1.90
Outstanding, end balance (in dollars per share)					$ 1.90
April 2020
Number of Underlying Shares
Outstanding, end balance (in shares)					11,308,314
July 2019 Series A warrants
Number of Underlying Shares
Outstanding, end balance (in shares)					338,155
Weighted Average Exercise Price Per Share
Exchanged during the period (in dollar per share)				$ 8.75
Outstanding, end balance (in dollars per share)					$ 8.75
July 2019 Series B warrants
Number of Underlying Shares
Outstanding, beginning balance (in shares)						120,000
Granted during the period (in shares)						(120,000)
Exercised during period (in shares)						120,000	60,000
Outstanding, end balance (in shares)							120,000
Exchanged during period (in shares)				180,000
Weighted Average Exercise Price Per Share
Exercised during period (in dollar per share)						$ 8.75
Exchanged during the period (in dollar per share)				$ 8.75
Outstanding, end balance (in dollars per share)					$ 8.75
Warrants Exercise Period				6 months
Net proceeds						$ 1,100,000	$ 500,000
April 2020 Series A warrants
Number of Underlying Shares
Outstanding, end balance (in shares)					44,000
Weighted Average Exercise Price Per Share
Outstanding, end balance (in dollars per share)					$ 7.50
April 2020 Series B warrants
Number of Underlying Shares
Outstanding, end balance (in shares)					10,000
Weighted Average Exercise Price Per Share
Outstanding, end balance (in dollars per share)					$ 7.50
November 2023 Series A Warrants
Number of Underlying Shares
Granted during the period (in shares)					6,000,000
Outstanding, end balance (in shares)					6,000,000
Weighted Average Exercise Price Per Share
Granted (in dollars per share)					$ 0.70
Outstanding, end balance (in dollars per share)					$ 0.70
November 2023 Series B Warrants
Number of Underlying Shares
Granted during the period (in shares)					3,000,000
Outstanding, end balance (in shares)					3,000,000
Weighted Average Exercise Price Per Share
Granted (in dollars per share)					$ 0.70
Outstanding, end balance (in dollars per share)					$ 0.70
November 2023 Pre-Funded Warrants
Number of Underlying Shares
Granted during the period (in shares)					1,287,512
Exercised during period (in shares)					(798,940)
Outstanding, end balance (in shares)					488,572
Weighted Average Exercise Price Per Share
Granted (in dollars per share)					$ 0.0001
Exercised during period (in dollar per share)					0.0001
Outstanding, end balance (in dollars per share)	$ 0.0001				$ 0.0001
Number of common shares which can be purchased with each warrant	1
Net proceeds	$ 79.89
June 2023 Private Placement
Weighted Average Exercise Price Per Share
Outstanding, end balance (in dollars per share)		$ 1.90
Warrants Exercise Period		6 months
Number of common shares which can be purchased with each warrant		1,427,587
Gross proceeds from common stock sale								$ 2,600,000
June 2023 Private Placement | Series A Warrants
Number of Underlying Shares
Outstanding, beginning balance (in shares)						44,000	100,000
Exercised during period (in shares)							56,000	200,000
Outstanding, end balance (in shares)							44,000	100,000
Weighted Average Exercise Price Per Share
Net proceeds							$ 400,000
June 2023 Private Placement | Series B Warrants [Member]
Number of Underlying Shares
Outstanding, beginning balance (in shares)						10,000	10,000
Exercised during period (in shares)								140,000
Outstanding, end balance (in shares)							10,000	10,000
Registered Offering [Member] | July 2019 Series A warrants
Number of Underlying Shares
Exercised during period (in shares)						8,000
Outstanding, end balance (in shares)					338,155
Weighted Average Exercise Price Per Share
Warrants Exercise Period				6 months
Common shares issuable upon exercise						100,000
Registered Offering [Member] | July 2019 Series B warrants
Weighted Average Exercise Price Per Share
Number of common shares which can be purchased with each warrant				1
Common Stock | June 2023 Private Placement
Weighted Average Exercise Price Per Share
Common shares issuable upon exercise			450,000
Stock issued during period shares new issues (in shares)			600,000
Common Stock | June 2023 Private Placement | Series A Warrants
Weighted Average Exercise Price Per Share
Common shares issuable upon exercise			300,000
Common Stock | June 2023 Private Placement | Series B Warrants [Member]
Weighted Average Exercise Price Per Share
Common shares issuable upon exercise			150,000
Common Stock | Registered Offering [Member] | July 2019 Series A warrants
Weighted Average Exercise Price Per Share
Stock issued during period shares new issues (in shares)				346,155